Onconetix, Inc.
ONCO
$3.02
$0.051.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.34% | 153.70% | 4,214.70% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.34% | 153.70% | 4,214.70% | -- | -- |
| Cost of Revenue | -80.65% | -40.29% | 23.90% | -- | -- |
| Gross Profit | 205.28% | 197.20% | 193.60% | -- | -- |
| SG&A Expenses | -62.35% | -58.37% | -38.85% | 44.86% | 89.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -64.58% | -58.08% | -40.49% | 28.10% | 45.09% |
| Operating Income | 69.18% | 66.72% | 54.44% | -14.48% | -33.93% |
| Income Before Tax | 15.13% | -24.50% | -59.63% | -183.11% | -216.77% |
| Income Tax Expenses | -1,068.35% | -588.23% | -8,195.24% | -- | -- |
| Earnings from Continuing Operations | 16.83% | -22.85% | -56.89% | -182.35% | -216.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.83% | -22.85% | -56.89% | -182.35% | -216.27% |
| EBIT | 69.18% | 66.72% | 54.44% | -14.48% | -33.93% |
| EBITDA | 70.31% | 69.16% | 58.44% | -9.79% | -30.58% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |